Former president and CEO of Good Start Genetics, Donnie Hardison, is joining the board of directors at HTG Molecular Diagnostics.

Hardison brings to the board two decades of executive experience with diagnostic and pharmaceutical companies, as well as 17 years of work experience with SmithKline.

“We are incredibly honored to have Don join our board,” HTG President and CEO T.J. Johnson said. “Don’s career experience, industry knowledge and leadership capabilities will be tremendous assets for our board and management team.”

Hardison is expected to apply his background as an executive and sales manager with industry-specific experience to further HTG's work.

“I am very excited to have the opportunity to work with T.J., his team and the board as they continue their important work in democratizing NGS-based molecular profiling," Hardison said. "I believe the company’s technology has the potential to enable more precise diagnosis and delivery of individually tailored treatment at the local level.”

HTG Molecular Diagnostics is a Tucson-based company which develops instruments and platforms to serve the precision medicine field.